Aileron Therapeutics Inc (NASDAQ:ALRN)
| 1.36 Delayed Data As of Mar 24 |  +0.005 / +0.37%Today’s Change | 1.25 Today|||52-Week Range 15.00 | -42.83% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2015 | 2016 | 2017 | 2018 | |||
| Operating Activities | Net Income / Starting Line | -12.9M | -18.1M | -22.6M | -31.5M | |
| Depreciation | 325.0K | 232.0K | 129.0K | 218.0K | ||
| Total Other Cash Flow | 605.0K | 2.2M | 1.6M | 3.0M | ||
| Funds From Operations | -11.9M | -15.7M | -20.9M | -28.3M | ||
| Funds From/For Other Operating Expenses | -238.0K | -695.0K | -358.0K | -387.0K | ||
| Net Cash Flow - Operating Activities | -11.7M | -15.0M | -20.5M | -27.9M | ||
| Investing | Increase In Investments | -2.4M | -12.7M | -71.1M | -31.2M | |
| Decrease In Investments | 13.1M | 12.6M | 32.3M | 60.3M | ||
| Capital Expenditures | -94.0K | 0.00 | -142.0K | -4.4M | ||
| Net Cash Flow Investing | 10.6M | -25.0K | -38.9M | 24.7M | ||
| Financing | Short Term Borrowings | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Long Term Borrowings | 0.00 | 0.00 | 0.00 | 2.5M | ||
| Long Term Debt Reduction | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Net Proceeds Stock Sale | -1.4M | 32.0M | 50.6M | 42.0K | ||
| Common Preferred Redeemed | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Common Dividends | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Cash Dividends Paid - Total | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Other Sources - Financing | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Other Uses - Financing | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Net Cash Flow - Financing | -1.4M | 32.0M | 50.6M | 2.5M | ||
| Exchange Rate | Effect of Exchange Rate on Cash | -- | -- | -- | -- | -- |
| Net Change In Cash | -2.4M | 16.9M | -8.9M | -723.0K | ||
